Delivery Order SPE2DB24D9238-SPE2DB24FDQHY
- Not listed
- This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, was issued by the Defense Logistics Agency (DLA) as a firm fixed-price delivery order under a $499,999,999 Indefinite Delivery Contract (IDC). The contract covers the supply of a diverse range of pharmaceutical products, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables, to support the medical needs of the Department of Defense (DoD)...
- This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, is a firm fixed-price delivery order with a value of $3,094.80. The award was made by the Defense Logistics Agency (DLA), a component of the U.S. Department of Defense, and supports the agency's Medical Supply Chain division. The contract is for the delivery of Xolair 150 mg/mL syringes, a specialized pharmaceutical product. This award is part of a larger indefinite delivery contract (IDC) with the DLA...
- This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, is a firm fixed-price delivery order valued at $35,590.20. The contract was awarded by the Defense Logistics Agency (DLA) under the Medical Supply Chain division and has no set-aside designation. The contract covers the delivery of Xolair 150mg vials, a specialized injectable biologic medication, to support the recurring medical supply needs of military health facilities...
- This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, is a firm fixed-price delivery order (SPE2DB24FL0H6) under the Defense Logistics Agency's (DLA) SPE2DB program. The $9,284.40 award is for the supply of XOLAIR 75 MG/0.5 ML SYRINGE 0.5ML, a pharmaceutical product, to fulfill the recurring medical supply needs of military health facilities. DMS Pharmaceutical Group is an established federal contractor that provides a comprehensive range of pharmaceutical...
- This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, is a firm fixed-price delivery order valued at $38,685.00. The award was made by the Defense Logistics Agency (DLA) under the SPE2DB program, which is an indefinite delivery contract valued up to $499,999,999 that runs through December 31, 2025. This contract allows the DLA to issue delivery orders for a comprehensive range of pharmaceutical items, including branded and generic...
- This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, is a firm fixed-price delivery order valued at $7,737.00 for the supply of Xolair 150 mg/ml syringes. The award was made by the Defense Logistics Agency (DLA) under the Medical Supply Chain program, which facilitates the distribution of pharmaceutical products and medical supplies to Department of Defense (DoD) healthcare facilities worldwide. The contract has no set-aside designation and is part of a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $9,284.40, is a firm fixed-price delivery order for the supply of XOLAIR 150 MG/ML SYRINGEML, a specialized pharmaceutical product. The award is part of a larger indefinite delivery contract (IDC) between DMS Pharmaceutical Group and the DLA under the SPE2DB program, valued at...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $1,547.40 firm fixed-price delivery order is for the supply of XOLAIR 150 MG/ML SYRINGEML, a specialized pharmaceutical product. This award is part of a larger $499,999,999 indefinite delivery contract (IDC) under the DLA's SPE2DB program, which allows the agency to issue delivery orders for a...
- This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, is a firm fixed-price delivery order valued at $9,284.40. The contract was awarded by the Defense Logistics Agency (DLA) and has no set-aside designation. It is part of the DLA's larger SPE2DB Indefinite Delivery Contract (IDC) valued at up to $499,999,999, which allows the agency to issue delivery orders for a comprehensive range of pharmaceutical products to support the medical supply needs of...
- This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, was issued by the Defense Logistics Agency (DLA) under the Medical Supply Chain division. The $9,671.25 firm fixed-price delivery order is for the pharmaceutical product XOLAIR 150 MG/ML SYRINGEML, with a completion date of June 4, 2024. DMS Pharmaceutical Group holds a significant $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program, which allows the DLA to issue delivery...
- SPE2DB24D9238Indefinite Delivery Contract
- SPE2DB24D9238-SPE2DB24FDQHYDelivery Order
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, is a Delivery Order under the Defense Logistics Agency's (DLA) SPE2DB indefinite delivery contract (IDC). The IDC, valued up to $499,999,999, allows the DLA to issue firm fixed-price delivery orders for a wide range of pharmaceutical products to support the recurring medical supply needs of military health facilities worldwide. The specific award, valued at $9,284.40, is for the supply of XOLAIR 150 MG/ML SYRINGE, a pharmaceutical product used in the treatment of various medical conditions. This contract has no set-aside designation. As a prime vendor for the DLA, DMS Pharmaceutical Group provides a comprehensive array of branded, generic, and specialty medications, including flumazenil injections, prednisone tablets, and oncology drugs like Keytruda and Xolair, to military and Department of Veterans Affairs (VA) healthcare facilities across the United States.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $9.3k | 6/18/24 |